- Anserine ELISA Kits
- Avian ELISA Kits
- Bovine ELISA Kits
- Canine ELISA Kits
- Camel ELISA Kits
- Chicken ELISA Kits
- Monkey ELISA Kits
- Duck ELISA Kits
- Equine ELISA Kits
- Fish ELISA Kits
- Feline ELISA Kits
- Guinea Pig ELISA Kits
- Goose ELISA Kits
- Goat ELISA Kits
- Gymnuromys ELISA Kits
- Human ELISA Kits
- Hamster ELISA Kits
- Horse ELISA Kits
- Lizard ELISA Kits
- Mouse ELISA Kits
- Porcine ELISA Kits
- Pigeon ELISA Kits
- Rat ELISA Kits
- Sheep ELISA Kits
- Zebra ELISA Kits
- Deer ELISA Kits
September 26, 2024
We're excited to announce the launch of the brand-new version of our website. Packed with user-friendly improvements and a host of powerful new tools, the site is designed to better support our growing community of researchers and professionals.
Here's what's new:
- Comprehensive Citations: A curated collection of citations from research studies and publications where our products and services have been utilized, making it easier for researchers to reference and validate their work.
- Easy Access to ELISA Protocols: Step-by-step ELISA protocols are now available online, providing easy access to detailed instructions and guidelines for performing assays using our ELISA kits.
- Comprehensive ELISA Kit FAQ: A dedicated FAQ section to address common questions about our ELISA kits, ensuring users have the information they need for optimal results.
- Vital Data Resources: We've published critical data sets and resources to assist researchers in their workflows and provide greater transparency in product information.
This update reflects our commitment to supporting the research community with high-quality resources and information. We invite you to explore the new features and leave your feedback for us.
NeoBioScience and BioModels are gearing up to launch their drug screening research collaboration aimed at speeding the development of new nutrition and medicines to inflammatory joint diseases. The innovative collaboration will combine worldclass immunological research by NeoBioScience investigators with BioModels, one of the world's leading in vitro and in vivo model companies. The goal is to develop new treatments for inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.'The NeoBioScience scientists are extremely excited about this tremendous opportunity to collaborate with scientists at BioModels,' said PC Zhu, Ph.D., NeoBioScience's CEO. 'This unique scientific alliance should significantly enhance our efforts to push forward with ground-breaking research in immunology and inflammation and, in particular, it should enhance our ability to translate basic discoveries into the clinical setting.'Under the program, researchers at both institutions will develop collaborative grant proposals in the areas of immunology and inflammation.
NeoBioScience is proud to announce a new technology collaboration between the Xia’s laboratory at Harvard Medical School and the R&D department of NeoBioScience, Inc. NeoBioScience will build up a zebra fish facility and launch drug research using this model. 'This scientific alliance should significantly enhance our efforts to push forward with zebra fish based drug screening.' PC Zhu, Ph.D., NEO's Founder.
Among the model systems for studying development, the zebrafish has become prized because its transparent embryo develops outside the mother's body. The zebrafish has helped biologists identify many genes involved in embryogenesis and, because it's a vertebrate animal, has become a valuable resource for identifying genes involved in human disease.